You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 1, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Christian Grimm1, Eduardo Aneiros, Marcel de Groot
1Pain Research Unit, Pfizer Global Research and Development, Sandwich Laboratories, Kent, UK. Christian.Grimm2@pfizer.com
Transient Receptor Potential Vanilloid 1 (TRPV1) channels are key pain targets. Understanding their activation by heat and protons is crucial for developing safer pain relief drugs without side effects like hyperthermia.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: